Overview
Comparison for Efficacy and Safety of Bowel Preparation Between Oral Sulfate Table and 2L-polyethylene Glycol/Ascorbate in Elderly
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2024-02-01
2024-02-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study compares the effectiveness and stability of intestinal tablet (OST), an oral sulfate table (OST), developed in the form of pills, with 2L-PEG/Asc for examinees aged 70 or older who are scheduled for colonoscopy.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Pharmbio Korea Co., Ltd.
Criteria
Inclusion Criteria:- age over 70
- Patients who is scheduled a colonoscopy
- Patients who is informed and give a consent in voluntary
Exclusion Criteria:
- History of colectomy
- Patients over American Society of Anesthesiology class III
- Patients who has difficulty swallowing
- In the case of abnormal findings requiring treatment in the basic blood test
- Patients with uncontrollable chronic diseases
- Patients suspected of having Paralytic ileus or intestinal obstruction.
- Patients who complains of alarm sign (severe abdominal pain, weight loss, anemia,
gastrointestinal bleeding, etc.)
- Patients who has a history of drug abuse and addiction
- Patients who for any reason, are deemed by the Investigator to be inappropriate for
this study